Prestige Consumer Healthcare
221 hedge funds and large institutions have $1.94B invested in Prestige Consumer Healthcare in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 87 increasing their positions, 79 reducing their positions, and 45 closing their positions.
59% more call options, than puts
Call options by funds: $388K | Put options by funds: $244K
10% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 79
0.28% more ownership
Funds ownership: 124.96% → 125.24% (+0.28%)
3% less capital invested
Capital invested by funds: $2B → $1.94B (-$59.3M)
8% less funds holding
Funds holding: 241 → 221 (-20)
42% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 45
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$22.5M |
| 2 |
SCM
Sterling Capital Management
Charlotte,
North Carolina
|
+$15.2M |
| 3 |
ACB
Aristotle Capital Boston
Boston,
Massachusetts
|
+$14.5M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$13.1M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$9.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$24.1M |
| 2 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$22.6M |
| 3 |
JP Morgan Chase
New York
|
-$9.8M |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$8.81M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.76M |
PBH Hedge Fund Activity: Q1 2019 in Review
221 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q1 2019, worth a combined $1.94B — down 3% from $2B a quarter earlier.
Sellers outnumbered buyers: 45 funds closed out of PBH and 26 opened new positions — a net loss of 19 holders — while 79 trimmed existing stakes and 87 added.
The largest buyer was Goldman Sachs, adding an estimated $22.5M. The largest seller was Fidelity Investments, cutting an estimated $24.1M.
- 221 institutional investors held Prestige Consumer Healthcare (PBH) as of Q1 2019, down from 241 in Q4 2018.
- Funds reported $1.94B of Prestige Consumer Healthcare stock for Q1 2019, down 3% quarter-over-quarter.
- 26 funds opened new Prestige Consumer Healthcare positions in Q1 2019 and 45 closed out, a net change of -19 holders.
- The largest Prestige Consumer Healthcare buyer in Q1 2019 was Goldman Sachs, an estimated $22.5M added.
- The largest Prestige Consumer Healthcare seller in Q1 2019 was Fidelity Investments, an estimated $24.1M sold.
Based on aggregated 13F filings for Q1 2019.